Biosimilars: FDA finalizes supplement classification guidance
Regulatory NewsJoanne S. Eglovitch
Biologics License Application (BLA)Biologics/ biosimilars/ vaccinesBiotechnologyBsUFAChemistry, Manufacturing and Controls (CMC)Regulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)